Livzon Pharmaceutical Group Inc. (1513.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 22.88B |
| Enterprise Value | 17.42B |
| P/E Ratio | 14.08 |
| PEG Ratio | -0.65 |
| Price/Sales Ratio | 2.2 |
| Price/Book Ratio | 1.77 |
| Enterprise/Revenue | 1.9 |
| Enterprise/EBITDA | 7.37 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.16 |
| Operating Margin | 0.2 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.12 |
Income Statement
| Revenue | 12.02B |
| Revenue/Share | 12.1 |
| Gross Profit | 7.92B |
| EBITDA | 3.1B |
| Net Income | 2.02B |
| Diluted EPS | 2.27 |
Balance Sheet
| Total Cash | 8.19B |
| Total Cash/Share | 9.23 |
| Total Debt | 4.24B |
| Total Debt/Equity | 0.32 |
| Current Ratio | 1.55 |
| Book Value Per Share | 16.44 |
Price History
| 52-Week Change | -43.84 |
| 52-Week High | 37.56 |
| 52-Week Low | 19.8 |
| Moving Average 50 Days | 24.32 |
| Moving Average 200 Days | 27.29 |
Statistics
| Average Volume | 1.12M |
| Shares Outstanding | 1.09B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.43 |
| Trailing Annual Dividend Yield | 5.37 |
| Payout Ratio | 1.11 |
| Last Split Factor | 13:10 |
| Last Split Date | July 03, 2019 |
AD
